Results
Differentially Expressed miRNAs List
miRNA ID | Source ID | Cancer Type | Cancer Subtype | Cell Line | Design | logFC | Expression Status | Experiment ID |
---|---|---|---|---|---|---|---|---|
hsa-miR-154 | GSE5244 | uterus cancer | uterus cancer | N/A | cancer vs normal | -0.61 | DOWN | EXP00030 |
hsa-miR-154 | GSE18392 | colon cancer | colon cancer | N/A | cancer vs normal | -0.61 | DOWN | EXP00090 |
hsa-miR-154* | GSE18392 | colon cancer | colon cancer | N/A | cancer vs normal | 0.19 | UP | EXP00090 |
hsa-miR-154 | GSE22058 | hepatocellular carcinoma | hepatocellular carcinoma | N/A | cancer vs normal | -0.27 | DOWN | EXP00100 |
hsa-miR-154 | GSE21036 | prostate cancer | prostate cancer | N/A | cancer vs normal | -0.27 | DOWN | EXP00101 |
hsa-miR-154 | GSE6857 | hepatocellular carcinoma | hepatocellular carcinoma | N/A | cancer vs normal | 1.10 | UP | EXP00081 |
hsa-miR-154 | GSE13030 | brain cancer | brain cancer | N/A | cancer vs normal | -0.92 | DOWN | EXP00066 |
hsa-miR-154 | GSE13030 | brain cancer | brain cancer | N/A | cancer vs normal | -1.74 | DOWN | EXP00067 |
hsa-miR-154 | GSE15008 | lung cancer | lung cancer | N/A | cancer vs normal | 0.37 | UP | EXP00070 |
hsa-miR-154* | GSE2399 | lymphoma | lymphoma | Namalwa | subtype1 vs substype2 | -1.31 | DOWN | EXP00016 |
hsa-miR-154 | GSE2564 | lung cancer | lung cancer | N/A | cancer vs normal | -1.53 | DOWN | EXP00022 |
hsa-miR-154 | GSE2564 | uterus cancer | uterus cancer | N/A | cancer vs normal | -1.04 | DOWN | EXP00023 |
hsa-miR-154 | GSE13030 | brain cancer | brain cancer | N/A | cancer vs normal | -1.16 | DOWN | EXP00065 |
hsa-miR-154* | GSE2399 | lymphoma | lymphoma | Namalwa | cancer vs normal | -1.12 | DOWN | EXP00004 |
hsa-miR-154 | GSE18392 | colon cancer | colon cancer | N/A | cancer vs normal | -0.56 | DOWN | EXP00091 |